Pfizer to Make $54 Billion Off Treating COVID Over and Over

Pfizer expects record profits in 2022 due to its COVID-19 shots and antiviral medication.

STORY AT-A-GLANCE

• Pfizer is expecting record-high revenue in 2022, courtesy of COVID-19

• It’s predicting $32 billion in profits from its COVID-19 shots and another $22 billion from Paxlovid, for a total of $54 billion

• Overall, Pfizer forecasted 2022 sales of $98 billion to $102 billion

• First, Pfizer profits from the shots; next, when they don’t work to preve…